Geneos Wealth Management’s Morgan Stanley Pathway Small-Mid Cap Equity ETF MSSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-32
Closed -$1.63K 2581
2025
Q3
$1.63K Hold
32
﹤0.01% 2348
2025
Q2
$1.49K Sell
32
-32
-50% -$1.39K ﹤0.01% 2885
2025
Q1
$2.76K Buy
+64
New +$2.98K ﹤0.01% 2910

Other funds holding MSSM

Geneos Wealth Management's MSSM Position: Q4 2025 in Review

Geneos Wealth Management sold out of Morgan Stanley Pathway Small-Mid Cap Equity ETF (MSSM) in Q4 2025, closing a stake of 32 shares — an estimated $1.63K sold.

Geneos Wealth Management first reported a position in MSSM in Q1 2025 and held it in 3 quarters. The position peaked at $2.76K in Q1 2025. 17 funds tracked by Wall St. Rank hold MSSM as of Q4 2025.

  • Geneos Wealth Management reported no remaining Morgan Stanley Pathway Small-Mid Cap Equity ETF position as of Q4 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 32 Morgan Stanley Pathway Small-Mid Cap Equity ETF shares in Q4 2025, an estimated $1.63K.
  • Geneos Wealth Management first reported a position in Morgan Stanley Pathway Small-Mid Cap Equity ETF in Q1 2025 and held it in 3 quarters.
  • Geneos Wealth Management's Morgan Stanley Pathway Small-Mid Cap Equity ETF position peaked at $2.76K in Q1 2025.
  • 17 funds tracked by Wall St. Rank held Morgan Stanley Pathway Small-Mid Cap Equity ETF as of Q4 2025.

Based on Geneos Wealth Management's 13F filing for Q4 2025, filed 28 Jan 2026.